Search

Author/Creator Pellet, Pascale

1. 258 Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial. (12th April 2019)

Authors:
Tahir, Hasan; Mease, Philip J; Kavanaugh, Arthur; Reimold, Andreas; Rech, Jürgen; Hall, Stephen; Geusens, Piet; Pellet, Pascale; Delicha, Eumorphia Maria; Pricop, Luminita; Mpofu, Shephard
Journal:
Rheumatology
Issue:
Volume 58(2019)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. FRI0451 SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5 YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL. (June 2019)

Authors:
Mease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Jürgen; Hall, Stephen; Geusens, Piet; Pellet, Pascale; Delicha, Eumorphia Maria; Pricop, Luminita; Mpofu, Shephard
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
917
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial. Issue 2 (13th August 2018)

Authors:
Mease, Philip J; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Jürgen; Hall, Stephen; Geusens, Piet; Pellet, Pascale; Delicha, Evie Maria; Mpofu, Shephard; Pricop, Luminita
Journal:
RMD open
Issue:
Volume 4:Issue 2(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5‐year Results from the Phase 3 FUTURE 1 Study. Issue 1 (14th November 2019)

Authors:
Mease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Juergen; Hall, Stephen; Geusens, Piet; Pellet, Pascale; Delicha, Eumorphia Maria; Pricop, Luminita; Mpofu, Shephard
Journal:
ACR open rheumatology
Issue:
Volume 2:Issue 1(2020)
Page Start:
18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial. Issue 10235 (9th May 2020)

Authors:
McInnes, Iain B; Behrens, Frank; Mease, Philip J; Kavanaugh, Arthur; Ritchlin, Christopher; Nash, Peter; Masmitja, Jordi Gratacós; Goupille, Philippe; Korotaeva, Tatiana; Gottlieb, Alice B; Martin, Ruvie; Ding, Kevin; Pellet, Pascale; Mpofu, Shephard; Pricop, Luminita
Journal:
Lancet
Issue:
Volume 395:Issue 10235(2020)
Page Start:
1496
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗